SUBSCRIBE
SUBSCRIBE
News   Deals

QLT Inc. Gets Rights to Sell Visudyne in US from Novartis Pharma AG (JOBS)

October 19, 2009 | 
1 min read
Bookmark and Share

Reuters -- Canadian eye-care company QLT Inc said it restructured its pact with Novartis Pharma AG, giving it exclusive rights to sell anti-blindness treatment Visudyne in the United States.
Mergers & acquisitions
MORE ON THIS TOPIC
Glowing red up arrow surrounded by dollar signs in black background. Illustration of the concept of positive return on investment and business earnings
IPO
UPDATE: Neuroscience Biotech LB Pulls Off Upsized $285M IPO
September 11, 2025
 · 
2 min read
 · 
Annalee Armstrong
Podcast
Unpacking the Latest MAHA Report, RFK’s Senate Appearance, FDA’s CRL Drop and More
September 10, 2025
 · 
1 min read
 · 
Jef Akst
Rough road to money stock illustration
Mergers & Acquisitions
Hectic Markets, Emotions Lead Biotechs To Tack On CVRs
September 10, 2025
 · 
6 min read
 · 
Annalee Armstrong
Money coins flow from tap. Cash flow with tiny businessmen open the tap symbol illustration
Mergers & Acquisitions
Novartis’ Busy BD Team Keeps 2025 Bolt-On Deal Promises
September 9, 2025
 · 
2 min read
 · 
Annalee Armstrong